1. Chen, Hsin-Pao, Chen, Chih-I, Liu, Kuang-Wen, Chou, Chia-Lin, Lai, Hong-Yue. 2022. High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT. In Pathology, research and practice, 239, 154158. doi:10.1016/j.prp.2022.154158. https://pubmed.ncbi.nlm.nih.gov/36244249/
2. Takahashi, Takuto, Luzum, Jasmine A, Nicol, Melanie R, Jacobson, Pamala A. 2020. Pharmacogenomics of COVID-19 therapies. In NPJ genomic medicine, 5, 35. doi:10.1038/s41525-020-00143-y. https://pubmed.ncbi.nlm.nih.gov/32864162/
3. Ampuero, Javier, Del Campo, José Antonio, Rojas, Lourdes, Millán, Raquel, Romero-Gómez, Manuel. 2015. Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment. In Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 68, 56-60. doi:10.1016/j.jcv.2015.05.010. https://pubmed.ncbi.nlm.nih.gov/26071337/
4. Gray, Jennifer H, Owen, Ryan P, Giacomini, Kathleen M. 2003. The concentrative nucleoside transporter family, SLC28. In Pflugers Archiv : European journal of physiology, 447, 728-34. doi:. https://pubmed.ncbi.nlm.nih.gov/12856181/
5. Biswas, Mohitosh, Sawajan, Nares, Rungrotmongkol, Thanyada, Ershadian, Maliheh, Sukasem, Chonlaphat. 2022. Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies. In Frontiers in pharmacology, 13, 835136. doi:10.3389/fphar.2022.835136. https://pubmed.ncbi.nlm.nih.gov/35250581/
智鼠故事 
